Nathaniel Roy Landau (Nathaniel R Landau)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 19

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

bioRxiv : the preprint server for biology

Science advances

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Thomas D Norton, Rebecca Leibowitz, Nathaniel Roy Landau
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for immunotherapy of cancer 12 (4) (2024)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Hao Zhou, Nathaniel Roy Landau
Prophylaxis and Treatment of SARS-CoV-2 infection by an ACE2 Receptor Decoy. bioRxiv : the preprint server for biology (2023)
Takuya Tada, Belinda M Dcosta, Julia Minnee, Nathaniel Roy Landau
Vectored Immunoprophylaxis and Treatment of SARS-CoV-2 Infection. bioRxiv : the preprint server for biology (2023)
Ramanjit Kaur, Takuya Tada, Nathaniel Roy Landau
Restriction of SARS-CoV-2 replication by receptor transporter protein 4 (RTP4). mBio (2023)
Takuya Tada, Julia Minnee, Nathaniel Roy Landau
Vectored immunoprophylaxis and treatment of SARS-CoV-2 infection in a preclinical model. Proceedings of the National Academy of Sciences of the United States of America 120 (23) (2023)
Hao Zhou, Takuya Tada, Belinda M Dcosta, Nathaniel Roy Landau
Neutralization of SARS-CoV-2 Omicron BA.2 by Therapeutic Monoclonal Antibodies. bioRxiv : the preprint server for biology (2022)
Claudio Counoupas, Paco Pino, Alberto O Stella, Caroline Ashley, Hannah Lukeman, Nayan D Bhattacharyya, Takuya Tada, Stephanie Anchisi, Charles Metayer, Jacopo Martinis, Anupriya Aggarwal, Belinda M Dcosta, Warwick J Britton, Joeri Kint, Maria J Wurm, Nathaniel Roy Landau, Megan Steain, Stuart G Turville, Florian M Wurm, Sunil A David, James A Triccas
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens. Microbiology spectrum 10 (1) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Shaun M Christie, Takuya Tada, Yandong Yin, Amit Bhardwaj, Nathaniel Roy Landau, Eli Rothenberg
Single-virus tracking reveals variant SARS-CoV-2 spike proteins induce ACE2-independent membrane interactions. Science advances 8 (49) (2022)
Hao Zhou, Belinda M Dcosta, Marie I Samanovic, Mark J Mulligan, Nathaniel Roy Landau, Takuya Tada
B.1.526 SARS-CoV-2 variants identified in New York City are neutralized by vaccine-elicited and therapeutic monoclonal antibodies. bioRxiv : the preprint server for biology (2021)
Takuya Tada, Hao Zhou, Marie I Samanovic, Belinda M Dcosta, Amber Cornelius, Mark J Mulligan, Nathaniel Roy Landau
Comparison of Neutralizing Antibody Titers Elicited by mRNA and Adenoviral Vector Vaccine against SARS-CoV-2 Variants. bioRxiv : the preprint server for biology (2021)